J. Goldman & CO LP Wave Life Sciences Ltd. Transaction History
J. Goldman & CO LP
- $3.53 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding WVE
# of Institutions
196Shares Held
123MCall Options Held
323KPut Options Held
279K-
Ra Capital Management, L.P. Boston, MA18.2MShares$197 Million3.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.62MShares$104 Million0.22% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$89.3 Million1.98% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$72.8 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.71MShares$72.6 Million0.81% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $939M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...